Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Knowing when to revise your retirement strategy is key to staying on track. Learn the indicators that signal it's time for an adjustment.
21,255 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Despite a 2026 pullback, Advanced Micro Devices still shows fundamental strength in data-center AI demand and a diver...
When a CFO sells shares after exercising options, investors want the real story. This article explains what ambiq mic...
Real estate firms lean on AI-powered ads and social media to attract buyers and sellers as 2026 data shows shifting o...
This guide helps investors decode Workiva's 2025 earnings landscape. Learn which metrics matter, how to read manageme...
Investor nerves rose as here's gemini space station faced a sharp price drop this week. This piece breaks down what s...
As Heico reports Q2 2026 results, investors want to know if margins hold and growth remains intact. This article brea...
A new industry view reframes AI as a productivity boost that reshapes tasks, not a job killer, while Gen Z markets fi...
A new, sizable stake in Cal-Maine Foods hints at investor conviction despite a halved income last quarter. This piece...
Oklo’s latest move—acquiring Atomic Alchemy—signals more than a strategic expansion. This article breaks down what it...
Could the SanDisk brand—now part of Western Digital—spark a trillion-dollar valuation in five years? This article bre...
The private credit boom faces a real test as higher rates and shifting liquidity tighten the lending landscape. This ...